Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce O'Shaughnessy

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
Oncology (Williston Park, N.Y.)|February 11, 2004
Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experienceJoyce O'Shaughnessy
Seminars in Oncology Nursing|January 2, 2004
Chemotherapy-related cognitive dysfunction in breast cancerJoyce O'Shaughnessy
The Oncologist|December 22, 2005
Extending survival with chemotherapy in metastatic breast cancerJoyce O'Shaughnessy
Oncology (Williston Park, N.Y.)|November 19, 2002
Capecitabine and docetaxel in advanced breast cancer: analyses of a phase III comparative trialJoyce O'Shaughnessy
Seminars in Oncology|May 2, 2003
Gemcitabine and trastuzumab in metastatic breast cancerJoyce O'shaughnessy
Breast Cancer Research and Treatment|November 21, 2007
A decade of letrozole: FACEJoyce O'Shaughnessy
Clinical Journal of Oncology Nursing|July 25, 2015
Stomatitis Associated With Use of mTOR Inhibitors: Implications for Patients With Invasive Breast CancerJosephine Divers, Joyce O'Shaughnessy
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2010
Poly (ADP-ribose) polymerase as a novel therapeutic target in cancerChristina M Annunziata, Joyce O'Shaughnessy
The Oncologist|November 28, 2002
Treatment for anthracycline-pretreated metastatic breast cancerJoyce O'Shaughnessy, Chris Twelves, Matti Aapro
Future Oncology (London, England)|March 21, 2019
Perspectives on the mechanism of action and clinical application of eribulin for metastatic breast cancerJoyce O'Shaughnessy, Virginia Kaklamani, Kevin Kalinsky
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
Oncology (Williston Park, N.Y.)|February 11, 2004
Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experienceJoyce O'Shaughnessy
Seminars in Oncology Nursing|January 2, 2004
Chemotherapy-related cognitive dysfunction in breast cancerJoyce O'Shaughnessy
The Oncologist|December 22, 2005
Extending survival with chemotherapy in metastatic breast cancerJoyce O'Shaughnessy
Oncology (Williston Park, N.Y.)|November 19, 2002
Capecitabine and docetaxel in advanced breast cancer: analyses of a phase III comparative trialJoyce O'Shaughnessy
Seminars in Oncology|May 2, 2003
Gemcitabine and trastuzumab in metastatic breast cancerJoyce O'shaughnessy
Breast Cancer Research and Treatment|November 21, 2007
A decade of letrozole: FACEJoyce O'Shaughnessy
Clinical Journal of Oncology Nursing|July 25, 2015
Stomatitis Associated With Use of mTOR Inhibitors: Implications for Patients With Invasive Breast CancerJosephine Divers, Joyce O'Shaughnessy
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2010
Poly (ADP-ribose) polymerase as a novel therapeutic target in cancerChristina M Annunziata, Joyce O'Shaughnessy
The Oncologist|November 28, 2002
Treatment for anthracycline-pretreated metastatic breast cancerJoyce O'Shaughnessy, Chris Twelves, Matti Aapro
Future Oncology (London, England)|March 21, 2019
Perspectives on the mechanism of action and clinical application of eribulin for metastatic breast cancerJoyce O'Shaughnessy, Virginia Kaklamani, Kevin Kalinsky
Pageof 19